| Literature DB >> 35478637 |
Zhen-Zhu Zhao1, Qi-Lu Zhao1, Wei-Sheng Feng1, Hai-Rong He1, Meng Li1, Gui-Min Xue1, He-Ping Chen2, Ji-Kai Liu2.
Abstract
Ochracines F-L (1-7), seven previously undescribed chamigrane and cadinane sesquiterpenoids, together with four known chamigranes were isolated from cultures of the wood-decaying fungus Steccherinum ochraceum HFG119. Ochracines F-L were structurally characterized by extensive analysis of HRMS and NMR spectroscopic data. The relative configurations were assigned through a combination of NOE correlations and J-based configuration analysis (JBCA), while the absolute configurations were determined by X-ray single-crystal diffraction, and calculated methods (ECD, [α], 13C NMR). All the new isolates were evaluated for their cytotoxicity against five human cancer cell lines HL-60, SMMC-7721, A549, MCF-7, and SW-480, and inhibitory activity on NO production in RAW 264.7 macrophages. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35478637 PMCID: PMC9033458 DOI: 10.1039/d1ra03320d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Structures of compounds 1–11.
1H NMR data of compounds 1–5 (600 MHz)
| No. | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| 1 | 2.33, brd (20.0), 2.16, brd (20.0) | 2.11, brd (17.9), 2.06, brd (17.9) | 2.38, brd (19.3), 2.00, brd (19.3) | 2.18, brd (18.5), 2.07, brd (18.5) | 2.29, brd (18.5), 2.11, brd (18.5, 2.0) |
| 2 | 7.07, brs | 7.12, brs | 7.11, brs | 5.70, brs | 5.82, brs |
| 4 | 2.49, brd (18.0), 2.27, brd (18.0) | 2.45, overlapped, 2.30, m | 2.31, m, 2.25, m | 1.95, brd (18.0), 1.71, brd (18.0) | 2.19, m, 1.94, overlapped |
| 5 | 1.87, overlapped, 1.50, overlapped | 1.72, overlapped, 1.67, overlapped | 1.67, ddd (16.0, 10.0, 6.2), 1.58, ddd (16.0, 4.5, 4.5) | 1.90, brd (13.0), 1.54, brd (13.0) | 1.90, m, 1.85, m |
| 7 | 1.74, q (7.2) | 2.67, q (7.0) | 2.61, q (7.0) | ||
| 8 | 4.08, brd (9.3) | 5.88, s | |||
| 9 | 1.90, overlapped, 1.69, overlapped | 2.42, overlapped, 2.40, overlapped | 2.51, ddd (14.7, 6.0, 6.0), 2.38, ddd (14.7, 8.5, 6.5) | 3.46, ddd (11.5, 9.3, 5.0) | 2.64, d (17.0), 2.08, d (17.0) |
| 10 | 1.87, overlapped, 1.46, overlapped | 1.81, m, 1.71, overlapped | 1.81, ddd (13.7, 8.5, 6.0), 1.75, ddd (13.7, 6.5, 6.0) | 1.81, dd (13.3, 11.5), 1.59, dd (13.3, 5.0) | |
| 12 | 4.07, d (9.0), 3.57, d (9.0) | 1.16, s | 1.10 | 0.93, s | 0.96 |
| 13 | 0.70, s | 0.98, s | 1.11 | 0.83, s | 1.04 |
| 14 | 0.91, d (7.2) | 1.04, d (7.0) | 1.07, d (7.0) | 5.39, d (1.7), 4.78, d (1.7) | 1.98, s |
| 15 | 4.40, d (12.0), 4.36, d (12.0) | 4.07, d (13.4), 4.03, d (13.4) | |||
| 15-OAc | 2.05, s |
Measured in CD3OD.
Measured in CDCl3.
Interchangeable assignments.
13C NMR data of compounds 1–7 (150 MHz)
| No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| 1 | 29.4, CH2 | 27.4, CH2 | 32.7, CH2 | 29.6, CH2 | 27.9, CH2 | 40.0, CH | 39.5, CH |
| 2 | 142.4, CH | 142.4, CH | 141.8, CH | 125.0, CH | 123.5, CH | 35.6, CH2 | 40.9, CH |
| 3 | 131.7, C | 129.3, C | 129.4, C | 132.1, C | 137.7, C | 77.3, CH | 199.6, C |
| 4 | 22.2, CH2 | 22.7, CH2 | 22.1, CH2 | 23.8, CH2 | 24.0, CH2 | 138.4, C | 137.4, C |
| 5 | 31.0, CH2 | 28.3, CH2 | 23.9, CH2 | 26.6, CH2 | 30.6, CH2 | 126.1, CH | 149.2, CH |
| 6 | 39.0, C | 44.5, C | 43.6, C | 45.4, C | 44.0, C | 37.1, CH | 40.2, CH |
| 7 | 47.2, CH | 49.9, CH | 50.5, CH | 146.7, C | 170.9, C | 51.4, CH | 59.1, CH |
| 8 | 99.3, C | 214.3, C | 214.2, C | 74.5, CH | 127.3, CH | 123.8, CH | 202.6, C |
| 9 | 28.0, CH2 | 37.7, CH2 | 37.0, CH2 | 73.3, CH | 49.1, CH2 | 136.5, CH | 128.1, CH |
| 10 | 30.6, CH2 | 38.2, CH2 | 37.1, CH2 | 43.1, CH2 | 198.8, C | 77.4, C | 162.1, C |
| 11 | 35.8, C | 37.5, C | 37.5, C | 37.5, C | 40.6, C | 72.9, C | 28.1, CH |
| 12 | 73.3, CH2 | 23.7, CH3 | 25.2, CH3 | 24.7, CH3 | 25.0, CH3 | 28.3, CH3 | 21.0, CH3 |
| 13 | 17.7, CH3 | 26.2, CH3 | 24.6, CH3 | 24.1, CH3 | 24.0, CH3 | 29.8, CH3 | 21.5, CH3 |
| 14 | 13.8, CH3 | 11.8, CH3 | 12.5, CH3 | 109.8, CH2 | 24.5, CH3 | 21.5, CH3 | 15.7, CH3 |
| 15 | 170.8, C | 170.4, C | 170.9, C | 68.3, CH2 | 67.0, CH2 | 28.4, CH3 | 21.9, CH3 |
| 15-OAc | 171.1, C | ||||||
| 15-OAc | 21.2, CH3 |
Measured in CD3OD.
Measured in CDCl3.
Fig. 3Selected HMBC and 1H–1H COSY correlations of 1–7.
Fig. 4Selected NOE correlations of 1–4.
Fig. 2ORTEP drawing of compound 1.
Fig. 5Comparison of the calculated ECD spectrum for (6R,7S,8S,11R)-1 (σ = 0.22 eV, UV shift 0 nm) with the experimental spectrum of 1 in MeOH.
Fig. 6Comparison of the calculated ECD spectrum for (6R,7S)-2 (σ = 0.40 eV, UV shift −1 nm) with the experimental spectrum of 2 in MeOH.
Fig. 7Comparison of the calculated ECD spectra for (6S,7S)-3 (σ = 0.16 eV, UV shift −8 nm) with the experimental spectrum of 3 in MeOH.
1H NMR data of compounds 6 and 7 (150 MHz)
| No. | 6 | 7 |
|---|---|---|
| 1 | 2.60, dd (4.8, 4.8) | 3.24, m |
| 2 | 2.21, ddd (11.0, 5.0, 4.8), Heq, 1.87, d (11.0), Hax | 2.86, dd (16.3, 5.3), 2.78, dd (16.3, 5.6) |
| 3 | 4.04, d (5.0) | |
| 5 | 4.86, brs | 6.55, brs |
| 6 | 2.93, brs | 3.32, overlapped |
| 7 | 1.99, d (6.2) | 2.17, dd (8.5, 4.3) |
| 8 | 5.66, dd (10.3, 6.2) | |
| 9 | 5.99, d (10.3) | 5.81, brs |
| 11 | 2.02, m | |
| 12 | 1.31, s | 1.14, d (7.0) |
| 13 | 1.26, s | 0.92, d (7.0) |
| 14 | 1.67, s | 1.72, s |
| 15 | 1.21, s | 1.92, s |
Measured in CD3OD.
Measured in CDCl3.
Fig. 8Selected NOE correlations of 6 and 7.
Fig. 9Comparison of the calculated ECD spectra for (1S,3R,6R,7R,10R)-6 (6a) (σ = 0.22 eV, UV shift 0 nm) and (1R,3S,6S,7S,10S)-6 (6b) with the experimental spectrum of 6 in MeOH.
Fig. 10(A) Regression analysis of experimental versus calculated 13C NMR chemical shifts of 6 at GIAO B3LYP/6-31G(d) level; linear fitting was shown as a line. (B) Relative chemical shift errors between scaled 13C NMR and experimental 13C NMR for 6.
Fig. 11(A/C) Regression analysis of experimental versus calculated 13C NMR chemical shifts of 6α-7/6β-7 at GIAO B3LYP/6-31G(d) level. (B/D) Relative chemical shift errors between scaled 13C NMR and experimental 13C NMR for 6α-7/6β-7.